First Department of Anesthesiology, Toho University School of Medicine, Tokyo, Japan.
Clin Ther. 2009 Oct;31(10):2107-12. doi: 10.1016/j.clinthera.2009.10.012.
Pain on injection is a recognized adverse effect of propofol, an agent used to induce general anesthesia in surgical patients. Pretreatment with fentanyl has been reported to be effective in reducing propofol-induced pain.
The aim of this study was to compare the efficacy of intravenous pretreatment with fentanyl 50 microg, fentanyl 100 microg, and lidocaine 40 mg, preceded by venous occlusion, for reducing pain on injection of propofol in adult Japanese surgical patients.
This was a prospective, randomized, double-blind, placebo-controlled study. Adult Japanese surgical patients were randomized to 1 of 4 groups to receive intravenous fentanyl 50 microg, fentanyl 100 microg, lidocaine 40 mg, or placebo (0.9% isotonic saline). The drug administration was preceded by manual venous occlusion with a rubber tourniquet for 1 minute, followed by administering propofol 0.5 mg/kg injected into the largest dorsal vein of the hand through a 20-gauge intravenous cannula at the rate of 10 mg/sec. Pain on injection of propofol was assessed by an investigator who was blinded to group assignment. Patients were interviewed to assess pain intensity on injection using a 4-point verbal rating scale (0 = none; 1 = mild; 2 = moderate; and 3 = severe). Incidence and severity of pain were determined in each of the 4 study groups. Adverse events related to the study drug were recorded before the induction of anesthesia and after surgery. Patients were monitored for adverse events for 24 hours following surgery.
A total of 120 patients (70 men and 50 women; mean [SD] age, 44 [11] years; height, 160 [7] cm; weight, 56 [10] kg) completed the study. Each group comprised 30 patients. No significant between-group differences in demographic characteristics were found. The overall incidence of propofol-induced pain was 77% (23/30 patients) with fentanyl 50 microg (P = NS), 37% (11/30 patients) with fentanyl 100 microg (P = 0.001), and 33% (10/30 patients) with lidocaine 40 mg (P = 0.001) compared with 83% (25/30 patients) with placebo. The median pain score was lower in patients who received fentanyl 50 microg (1; P = NS), fentanyl 100 microg (0; P = 0.001), or lidocaine 40 mg (0; P = 0.001) than in those who received placebo (2). The incidence and severity of pain were significantly different between the fentanyl 50-microg and 100-microg groups (incidence, P = 0.002; severity, P = 0.001). However, there was no significant difference in the incidence and severity of such pain between the fentanyl 100-microg and lidocaine 40-mg groups. Both study drugs were well tolerated.
Preceded by venous occlusion for 1 minute, fentanyl 100 microg was not significantly different from lidocaine 40 mg in reducing pain during injection of propofol in these adult Japanese surgical patients. Fentanyl 50 microg was ineffective in reducing such pain compared with placebo.
疼痛是诱导全身麻醉患者注射丙泊酚的一种公认的不良反应。预先给予芬太尼已被报道可有效减轻丙泊酚诱导的疼痛。
本研究旨在比较静脉内预先给予芬太尼 50μg、芬太尼 100μg 和利多卡因 40mg 联合静脉闭塞预处理,以减轻日本成年手术患者注射丙泊酚时的疼痛。
这是一项前瞻性、随机、双盲、安慰剂对照研究。成年日本手术患者随机分为 4 组,分别接受静脉内给予芬太尼 50μg、芬太尼 100μg、利多卡因 40mg 或安慰剂(0.9%生理盐水)。在给予丙泊酚 0.5mg/kg 前 1 分钟,用橡胶止血带进行静脉闭塞,然后通过 20 号静脉套管以 10mg/sec 的速度注入手最大背静脉。由一名对分组情况不知情的研究者评估注射丙泊酚时的疼痛。患者在手术前和手术后被要求使用 4 分制口头评分量表评估注射时的疼痛强度(0=无;1=轻度;2=中度;3=重度)。在每个研究组中确定疼痛的发生率和严重程度。记录与研究药物相关的不良反应。在手术后 24 小时内监测患者的不良反应。
共有 120 名患者(70 名男性和 50 名女性;平均[标准差]年龄为 44[11]岁;身高为 160[7]cm;体重为 56[10]kg)完成了研究。每组 30 名患者。在人口统计学特征方面,各组间无显著差异。丙泊酚诱导的疼痛总发生率为 77%(23/30 例患者),与芬太尼 50μg(P=NS)、芬太尼 100μg(P=0.001)和利多卡因 40mg(P=0.001)相比,安慰剂组(83%,25/30 例患者)的发生率较低。接受芬太尼 50μg(1;P=NS)、芬太尼 100μg(0;P=0.001)或利多卡因 40mg(0;P=0.001)的患者的中位数疼痛评分低于接受安慰剂的患者(2)。芬太尼 50μg 组和 100μg 组之间疼痛的发生率和严重程度差异有统计学意义(发生率,P=0.002;严重程度,P=0.001)。然而,芬太尼 100μg 组和利多卡因 40mg 组之间这种疼痛的发生率和严重程度无显著差异。两种研究药物均耐受良好。
在静脉闭塞 1 分钟后,与利多卡因 40mg 相比,芬太尼 100μg 对减轻这些日本成年手术患者注射丙泊酚时的疼痛没有显著差异。芬太尼 50μg 与安慰剂相比,减轻疼痛无效。